英文【高盛】全球医疗保健生物制药2025年美国临床肿瘤学会（ASCO）会议关注要点
19 May 2025 | 5:00AM EDT Global: Healthcare: Biopharma: What to watch at ASCO 2025 Ahead of the 2025 American Society of Clinical Oncology (ASCO) conference (May
报告摘要
19 May 2025 | 5:00AM EDT Global: Healthcare: Biopharma: What to watch at ASCO 2025 Ahead of the 2025 American Society of Clinical Oncology (ASCO) conference (May
核心要点
- 19 May 2025 | 5:00AM EDT
报告信息
- 文件全名
- 《英文【高盛】全球医疗保健生物制药2025年美国临床肿瘤学会（ASCO）会议关注要点-20页.pdf》
- 适合读者
- 核心数据
- conference, demonstrating encouraging efficacy (50% overall response rate and 33%
- confirmed response rate, with two of 8 patients (25%) showing ongoing durable
- 核心议题
常见问题
《英文【高盛】全球医疗保健生物制药2025年美国临床肿瘤学会（ASCO）会议关注要点》主要包含哪些内容?
19 May 2025 | 5:00AM EDT Global: Healthcare: Biopharma: What to watch at ASCO 2025 Ahead of the 2025 American Society of Clinical Oncology (ASCO) conference (May核心数据:conference, demonstrating encouraging efficacy (50% overall response rate and 33%;confirmed response rate, with two of 8 patients (25%) showing ongoing durable。
这份报告覆盖哪一年、篇幅多大?
覆盖 2025 年,全文约 20。
这份报告是免费的吗?如何获取?
本报告免费查阅,登录资料宝后即可在线获取完整内容。
这份报告适合哪些读者?
适合战略规划、行业研究员等读者参考。
报告涉及哪些关键议题?
重点分析了生物制药等议题。
继续阅读
查看全部 →